|
End-of-day quote
Ghana S.E.
|
||
| - GHS | - |
|
| Market Cap | 5.2M 60.54M 4.66M 4.29M 3.88M 7.26M 493M 7.39M 50.99M 20.49M 259M 19.5M 19.08M 819M | P/E 2017 |
11.7x | P/E 2018 | 6.9x |
|---|---|---|---|---|---|
| Enterprise Value | 10.45M 122M 9.36M 8.62M 7.8M 14.59M 992M 14.86M 103M 41.19M 522M 39.2M 38.36M 1.65B | EV / Sales 2017 |
1.34x | EV / Sales 2018 | 1.05x |
| Free-Float |
26.89% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 915K | |
| +3.19% | +8.48% | +74.25% | +153.03% | 1,224B | |
| -0.73% | +2.09% | +46.41% | +87.64% | 662B | |
| +1.41% | +3.40% | +30.98% | +112.26% | 514B | |
| +0.42% | +2.88% | +54.92% | +69.67% | 388B | |
| +2.18% | +1.55% | +72.70% | +45.42% | 361B | |
| +1.12% | +3.80% | +35.82% | +59.72% | 302B | |
| +6.96% | +7.55% | +11.15% | +37.89% | 271B | |
| +1.15% | +4.19% | +59.72% | +78.16% | 249B | |
| +3.06% | +8.58% | +44.03% | +122.76% | 205B | |
| Average | +1.76% | +2.59% | +47.77% | +85.17% | 417.68B | |
| Weighted average by Cap. | +1.12% | +3.04% | +53.35% | +100.42% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 8.89M 104M 7.97M 7.34M 6.64M 12.42M 844M 12.65M 87.27M 35.07M 444M 33.37M 32.66M 1.4B | 9.91M 115M 8.88M 8.17M 7.4M 13.84M 941M 14.1M 97.25M 39.08M 495M 37.19M 36.39M 1.56B |
| Net income | 665K 7.75M 596K 549K 497K 929K 63.14M 946K 6.53M 2.62M 33.21M 2.5M 2.44M 105M | 762K 8.87M 683K 628K 569K 1.06M 72.3M 1.08M 7.47M 3M 38.02M 2.86M 2.8M 120M |
| Net Debt | 4.15M 48.31M 3.72M 3.42M 3.1M 5.79M 394M 5.9M 40.7M 16.35M 207M 15.56M 15.23M 653M | 5.25M 61.16M 4.71M 4.33M 3.92M 7.33M 498M 7.47M 51.52M 20.7M 262M 19.7M 19.28M 827M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
